Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Winer

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 10, 1998
An integrated genetic linkage map of the laboratory ratD M Brown, T C Matise, G Koike, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Blood Advances|May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 yearsShai Shimony, Geoffrey Fell, Evan C Chen, et al.
The Lancet. Haematology|February 2, 2019
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 studyNoelle Frey, Jun Ho Jang, Jeff Szer, et al.
Blood Cancer Journal|December 5, 2015
Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemiaJ L Reagan, L D Fast, M Nevola, et al.
Gynecologic Oncology|September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapyTenley R Klc, Sharon Wu, Annelise M Wilhite, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Leukemia Research|July 14, 2023
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemiaMaximilian Stahl, Gerard Giblin, Yiwen Liu, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 10, 1998
An integrated genetic linkage map of the laboratory ratD M Brown, T C Matise, G Koike, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
Blood Advances|May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 yearsShai Shimony, Geoffrey Fell, Evan C Chen, et al.
The Lancet. Haematology|February 2, 2019
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 studyNoelle Frey, Jun Ho Jang, Jeff Szer, et al.
Blood Cancer Journal|December 5, 2015
Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemiaJ L Reagan, L D Fast, M Nevola, et al.
Gynecologic Oncology|September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapyTenley R Klc, Sharon Wu, Annelise M Wilhite, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Leukemia Research|July 14, 2023
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemiaMaximilian Stahl, Gerard Giblin, Yiwen Liu, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Pageof 12